Skip to main content

Table 1 Clinical characteristics of 72 patients evaluated for extratumoral gene expression subtypes

From: Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients

  Total Active, N (%) Inactive, N (%)  
Menopausal Status     
   Pre 32 10 (31.3) 22 (68.7)  
   Post 32 15 (46.9) 17 (53.1)  
   Missing 8 2 (25.0) 6 (75.0)  
Breast Cancer Subtype     
   Normal-like 4 1 (25.0) 3 (75.0)  
   Luminal A 22 8 (36.4) 14 (63.6)  
   Luminal B 9 3 (33.3) 6 (66.7)  
   Her2+ 7 3 (42.9) 4 (57.1)  
   Basal-like 12 4 (33.3) 8 (66.7)  
   Missing 18 8 (44.4) 10 (55.6)  
ER status     
   Positive 44 19 (43.2) 25 (56.8)  
   Negative 23 7 (30.4) 16 (69.6)  
   Missing 5 1 (20.0) 4 (80.0)  
HER2 status     
   Positive 13 5 (38.5) 8 (61.5)  
   Negative 38 12 (31.6) 26 (68.4)  
   Missing 21 10 (47.6) 11 (52.4)  
Tumor size (cm)     
   0 to 2 25 14 (56.0) 11 (44.0)  
   2.1 to 4 24 9 (37.5) 15 (62.5)  
   4+ 19 4 (21.1) 15 (78.9)  
   Missing 4 0 (0.0) 4 (100)  
Tumor grade     
   1 6 3 (50.0) 3 (50.0)  
   2 18 4 (22.2) 14 (77.8)  
   3 28 13 (46.4) 15 (53.6)  
   Missing 20 7 (35.0) 13 (65.0)